Cite
HARVARD Citation
Gros, B. et al. (n.d.). P534 Effectiveness and safety of Adalimumab switch from originator to biosimilar in patients with inflammatory bowel disease in clinical remission. Journal of Crohn's and colitis. p. i486. [Online].